Witryna1 wrz 2024 · Comparison of patients treated with ADT alone with those treated with ADT and IMRT. The number of patients who received ADT monotherapy and ADT and IMRT was 33 (19.6%) and 22 (30.1%), respectively. The mean age of the patients was 77.1 ± 4.4 and 75.0 ± 5.8, respectively, with no difference between the two groups (p = 0.131). WitrynaWe report the long-term outcomes in a large cohort of patients treated with the combination of DE image-guided IMRT (IG-IMRT) and ADT. Methods and materials: Patients with localized prostate cancer were identified from a centralized database across an integrated cancer center. All patients received DE IG-IMRT, combined with ADT, …
Low incidence of late recurrence in patients with intermediate-risk ...
WitrynaIntroduction. Meta-analyses demonstrate that both dose-escalated external beam radiotherapy (DE-EBRT) 1 and androgen deprivation therapy (ADT) combined with radiotherapy 2 improve prostate cancer outcomes. However, it has been noted that there is little evidence supporting the use of dose escalation in patients also receiving ADT. … Witryna16 cze 2024 · To report grade ≥2 overall late rectal and urinary toxicities in patients (pts) with prostate cancer treated by intensity-modulated radiotherapy (IMRT) at 3 dose-levels. Identify predictors of radiation toxicity and report biochemical progression free survival (bPFS). A total of 277 pts were treated with 70Gy (10.8%), 74Gy (63.9%) and 80 Gy … fixing hole in ceiling
Intensity-modulated radiation therapy from 70Gy to 80Gy in …
Witryna8 mar 2024 · All patients received ADT (luteinizing hormone-releasing hormone agonist only), which started 3–6 months before RT and continued for a total duration of ≥12 months. Median duration of ADT was... Witryna12 sty 2024 · The authors conclude that. PSA ≤ 0.2 ng/dL at 7 months is prognostic for longer overall survival with ADT for metastatic hormone-sensitive prostate cancer … Witryna24 cze 2024 · PSA levels greater than 0.09 ng/mL can predict prostate cancer (PCa) overall survival, risk of metastasis, and other outcomes as early as 3 months following radiation and androgen deprivation... can my gyno diagnose lichen scherolsis